Document is current
Any future updates will be listed below
-
Authors
Machiraju, Devayani
Ziener, Christian H
Clementi, Elena
García-Asencio, Francisco
Hüllein, Jennifer
Richter, Jasmin
Lenoir, Bénédicte
Wiecken, Melanie
Hübschmann, Daniel
Jäger, Dirk
Hassel, Jessica C
-
Funding
Funding for this research was provided by:
Universitätsklinikum Heidelberg
- License Information
-
More Information
Article History
Received: 17 March 2025
Accepted: 24 June 2025
First Online: 19 July 2025
Declarations
:
: All clinical records were obtained with the approval of the Institutional Review Board (S-454/2015), and patients’ consents were obtained for scientific biobanking of peripheral blood (S-207/2005). MASTER study received Institutional Review Board approval from the Ethics Committee (Medical Faculty of Heidelberg University, reference number: S-206/2011.
: Not applicable.
: JCH has received honoraria from BMS, MSD, Novartis, Roche, Pierre Fabre, Sanofi, Almirall; consult-ant or advisory role: MSD, Pierre Fabre, Sunpharma; research funding: BMS; travel support: Pierre Fabre. DJ has received payment or honoraria from MSD, BMS, Roche, The Norwegian Cancer Society, Center for Modern Hospital Management Bejing, Gruppe 4 Filmproduktion GmbH, Centrum für integrierte Onkologie, Dept of Radiation Medicine; consultant or advisory role: OncoOne, CureVac, Amgen, Roche; travel support: BMS, CureVac, Amgen, Parexel, BCPPC, Berlin Institute of Health, Oncogenics, ForTra gGmbH, Pancreas Center Karolinska Institute of Sweden, Centrum für integrierte Onkologie, Bioevents-congress.com. EC and FG are employees of Oncobit company. DM, CZ, JH, BL, JR, MW, and DH declared no conflicts of interests.
